Evaluation of Histologic and Endoscopic Remission Induced by Infliximab in Moderate to Severe Ulcerative Colitis
Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to assess the relationship between microscopic Geboes index of
inflammation and clinical course of ulcerative colitis in patients treated with infliximab.
The investigators propose to test the hypothesis if infliximab is able to induce histological
remission and then change the clinical course of ulcerative colitis.
Phase:
Phase 4
Details
Lead Sponsor:
Grupo de Estudo da Doença Inflamatória Intestinal